
Last modified: 2025-09-29 10:33:36
It is important to understand how each step in downstream process of biologics such as antibodies or virus vectors can remove impurities for a DSP development. This symposium aims to understand the current situation and discuss on the future direction.
| Time | Paper ID | Title / Authors | Keywords | Topic code | Ack. number |
|---|---|---|---|---|---|
| Hall CI, Day 1 | |||||
| (15:00–17:40) (Chair: | |||||
| CI119 | Removal behavior of impurities during continuous purification of monoclonal antibody | mAb purification HCP chromatography | SY-71 | 357 | |
| CI120 | Analysis of filtration behavior using integrated column chromatography followed by virus filtration | chromatography integrated process virus filtration | SY-71 | 589 | |
| CI121 | [Invited lecture] Identification and Quantification of Problematic HCPs Using LC-MS | Biotherapeutics SWATH-MS Host Cell Proteins | SY-71 | 522 | |
| General discussion 1 | |||||
| CI123 | Development of a Novel Separation Membrane for AAV Vector Clarification Process | Membrane separation AAV vector Clarification | SY-71 | 339 | |
| CI124 | Process Optimization of Cell Lysis and Host DNA Digestion for High-Titer AAV Production | Adeno-Associated Virus Cell Lysis Endonuclease | SY-71 | 42 | |
| CI125 | Development of chromatographic techniques for the separation and analysis of AAV vectors | AAV Downstream process | SY-71 | 536 | |
| General discussion 2 | |||||
Technical program
Technical sessions (Wide)
(For narrow screen)
Session programs
Search in technical program
SCEJ 56th Autumn Meeting (Tokyo, 2025)
© 2025 The Society of Chemical Engineers, Japan. All rights reserved.
www4.scej.org